Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 65 0
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1
COV2-2196 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022 4 4
COV2-2130 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022 4 4
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Colchicine Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022 20 5
Excel (.xslx) CSV (.csv)